Prescribed Reading: CRISPR, Trump and FOURIER. Oh my! – BioPharma Dive
|
Prescribed Reading: CRISPR, Trump and FOURIER. Oh my!
BioPharma Dive Allergan is giving people one more reason to keep a close eye on CRISPR. The specialty pharma has teamed up with Editas Medicine to develop its eye-disease candidates, including the Cambridge biotech's lead program in Leber Congenital Amaurosis … |
